Clinical Trial Update: PrEP and Alcohol - Enhancing HIV Pre-Exposure Prophylaxis (PrEP) [NA]

View source ↗

Summary

Completed clinical trial evaluating how hazardous alcohol use affects HIV pre-exposure prophylaxis (PrEP) and reporting results on 2025-02-10.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Descovy (emtricitabine/tenofovir alafenamide)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Hazardous Alcohol Use | NA | Status: COMPLETED | Results posted: 2025-02-10